Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Eur Cell Mater ; 42: 166-178, 2021 09 24.
Article in English | MEDLINE | ID: mdl-34558056

ABSTRACT

Sheep are one of the many animal models used to investigate the pathophysiology of disc degeneration and the regenerative strategies for intervertebral disc (IVD) disease. To date, few studies have thoroughly explored ageing of ovine lumbar IVDs. Hence, the objective of the present study was to concomitantly assess the development of spontaneous age-related lumbar IVD degeneration in sheep using X-ray, magnetic resonance imaging (MRI) as well as histological analyses. 8 young ewes (< 48 months old) and 4 skeletally mature ewes (> 48 months old) were included. Disc height, Pfirrmann and modified Pfirrmann grades as well as T2-wsi and T2 times were assessed by X-ray and MRI. The modified Boos score was also determined using histology sections. Pfirrmann (2 to 3) and modified Pfirrmann (2 to 4) grades as well as Boos scores (7 to 13) gradually increased with ageing, while T2-weighted signal intensity (1.18 to 0.75), T2 relaxation time (114.36 to 70.65 ms) and disc height (4.1 to 3.2 mm) decreased significantly. All the imaging modalities strongly correlated with the histology (p < 0.0001). The present study described the suitability of sheep as a model of age-related IVD degeneration by correlation of histological tissue alterations with the changes observed using X-ray and MRI. Given the structural similarities with humans, the study demonstrated that sheep warrant being considered as a pertinent animal model to investigate IVD regenerative strategies without induction of degeneration.


Subject(s)
Intervertebral Disc Degeneration , Intervertebral Disc , Animals , Female , Intervertebral Disc/diagnostic imaging , Intervertebral Disc Degeneration/diagnostic imaging , Lumbar Vertebrae/diagnostic imaging , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Sheep , X-Rays
2.
Ann Pharm Fr ; 79(3): 255-265, 2021 May.
Article in English | MEDLINE | ID: mdl-33152321

ABSTRACT

BACKGROUND: Medical devices (MD) used to treat arrhythmias range from electrophysiological exploration catheters to intracardiac ablation catheters, and they are continuously undergoing optimization. The inclusion of innovative MD in Diagnosis Related Groups (DRG) of the French healthcare economic system can lead to financial imbalance for health institutions. The objective of this study was to compare cost-revenue analyses for interventional heart rhythm management in a high-volume French hospital between two time periods. METHODS: For 3 months in 2014 and 3 months in 2017, all of the patients admitted to the interventional rhythmic unit with arrhythmia were included retrospectively in this monocenter study. All arrhythmias were considered. The primary clinical endpoint was the difference between the expenses and incomes, calculated for each patient. The secondary endpoint was the breakdown of costs. RESULTS: 217 patients were included. In 2014 period, the analysis revealed a deficit of 409±1717 euros per patient and an overall deficit for the hospital of 44,635 euros. In 2017 period, the same evaluation indicated a deficit of 446±1316 euros per patient and an overall deficit for the hospital of 48,210 euros. The cost of MD accounts for a significant share of total expenses. CONCLUSION: The profitability for the cardiac rhythm activity at our facility was optimized between 2014 and 2017. The reliance on ambulatory care increased. However, the reduction in the expenses incurred did not increase the profitability for the facility. It was offset by a decrease in DRG tariffs. A flowchart-type structure based on these practices analyses for rhythmic disorder treatments was developed.


Subject(s)
Arrhythmias, Cardiac , Hospitalization , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/therapy , Costs and Cost Analysis , Hospitals , Humans , Retrospective Studies
3.
Eur Cell Mater ; 39: 18-47, 2020 01 06.
Article in English | MEDLINE | ID: mdl-31904862

ABSTRACT

Since low-back pain is increasing in ageing populations, current research efforts are focused on obtaining a better understanding of the pathophysiology of intervertebral disc degeneration and on developing new therapeutic strategies. This requires adequate and clinically relevant models of the disease process. Ex vivo models can provide insights into isolated aspects of the degenerative/regenerative processes involved; although, ultimately, in vivo models are needed for preclinical translational studies. Such models have been developed in numerous animal species with significant variations in size and disc physiology and their number is considerable. Importantly, the choice of the model has to be tailored to the aim of the study. Given the number of available options, it is important to have a good understanding of the various models of disc degeneration and to be fully aware of their advantages and limitations. After comparing the anatomy and histology of intervertebral discs in animals and humans, the present study provides an overview of the different models of in vivo disc degeneration. It also provides a comprehensive guide with suggested criteria to select the most appropriate animal model in a question-driven manner.


Subject(s)
Intervertebral Disc Degeneration/pathology , Lumbar Vertebrae/pathology , Animals , Biomechanical Phenomena , Disease Models, Animal , Humans , Intervertebral Disc Degeneration/diagnostic imaging , Intervertebral Disc Degeneration/physiopathology , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/physiopathology , Outcome Assessment, Health Care
4.
Diagn Interv Imaging ; 95(4): 427-34, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24231346

ABSTRACT

PURPOSE: This study has two aims. The first is to compare conventional lipiodol chemo-embolization (Trans Arterial Chemo-Embolization - TACE) to one using pre-loaded particles (Trans Arterial Chemo-Embolisation-Drug Eluted Bead - TACE-DEB) using a cost minimization study. The second is to define the fundable nature of TACE-DEB and the conditions under which it is cost-effective. MATERIALS AND METHODS: Retrospective study of patients treated by chemo-embolization (n=31: TACE; n=32: TACE-DEB) during the year 2010. The cost minimization study was conducted from the hospital perspective. Direct medical costs were calculated and compared using the readjusted ENCC (National Studies of Costs by Common Methodology) method. The affordability of the two techniques and definition of a cost-effective hypothesis (break-even point) were also established. RESULTS: All DRGs combined, lengths of stay (TACE: 4.90 ± 3.36; TACE-DEB: 5.03 ± 3.36) does not change significantly. An average upper mean cost for TACE-DEB is described (TACE: 2869.05 €; TACE-DEB: 3960.10 €). The affordability calculations in the study show that, overall, TACE-DEB can be funded regardless of DRG. A ratio of 1.3 procedures using the conventional (TACE) method would enable TACE-DEB procedures to be funded. CONCLUSION: This medico-economic analysis demonstrates that the TACE-DEB procedure is fundable.


Subject(s)
Carcinoma, Hepatocellular/economics , Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic/economics , Chemoembolization, Therapeutic/methods , Liver Neoplasms/economics , Liver Neoplasms/therapy , Aged , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/economics , Costs and Cost Analysis , Ethiodized Oil/administration & dosage , Ethiodized Oil/economics , Female , Humans , Male , Microspheres , Retrospective Studies
5.
Rev Stomatol Chir Maxillofac ; 92(6): 384-9, 1991.
Article in French | MEDLINE | ID: mdl-1784982

ABSTRACT

The surgical treatment of epidermoid carcinoma of the lip too rarely resorts to pluri-disciplinary confrontation, although all the possible techniques, i.e. surgery, curietherapy and radiation therapy, are effective. Curietherapy still is the choice method for large lesions, due to the quality of its aesthetic and functional results. The lymph node areas of N0 patients are neglected but should not be so, because the secondary evolution of an adenopathy has a poor prognosis. All the T2 and T3 patients with no general contraindication should undergo cervical exploration.


Subject(s)
Carcinoma, Squamous Cell/surgery , Lip Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Brachytherapy , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/secondary , Combined Modality Therapy , Female , Humans , Iridium Radioisotopes/therapeutic use , Lip Neoplasms/radiotherapy , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Prognosis
6.
Ann Anat Pathol (Paris) ; 25(1): 79-82, 1980.
Article in French | MEDLINE | ID: mdl-7458014

ABSTRACT

The authors by report a case of Brenner's tumour diagnosed during a hysterectomy carried out for a cervical carcinoma in situ in a menopausal patient with neoplastic adenopathy of unknown cause.


Subject(s)
Brenner Tumor/pathology , Ovarian Neoplasms/pathology , Female , Humans , Middle Aged
7.
Rev Stomatol Chir Maxillofac ; 80(3): 125-8, 1979.
Article in French | MEDLINE | ID: mdl-379973

ABSTRACT

The teeth should be conserved before radiotherapy: --in patients with good buccodental hygiene the teeth are conserved and fluoride treatment instituted,--when hygiene is only moderate, the mandibular teeth outside of the treated area are left in place and fluoride treatment is also attempted. The crowns are conserved, and an attempt is even made in some cases to apply them, as for example on the canines.--when hygiene is inexistant, all the teeth are extracted. Following radiotherapy, the authors will restore a prosthesis two months after irradiation in long-standing edentulons patients, and after 6 months for patients who have recently become edentulons. They sometimes recommend conservative treatment and a fixed prosthesis when the social context is favourable.


Subject(s)
Jaw/radiation effects , Mouth Rehabilitation , Radiotherapy , Dentures/adverse effects , Fluorides, Topical/therapeutic use , Humans , Jaw Diseases/prevention & control , Mouth/radiation effects , Mouth Diseases/etiology , Mouth, Edentulous/therapy , Osteoradionecrosis/prevention & control , Tooth Diseases/prevention & control , Ulcer/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...